Proteomics-based diagnostics developer Prevencio has appointed H. Perry Fell to be chairman of the board and Rhonda Rhyne to be president, CEO, and board director.

Fell formerly was chairman and CEO of NanoString Technologies and he co-founded Seattle Genetics. Rhyne has been president of CardioDynamics, and she founded the consulting company Rhyne Life Sciences.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.